Paul Nghiem

Fred Hutch Cancer Center — United States

Medicine · Health Sciences

79h-index23.4kcitations639works3.22yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Polyomavirus and related diseases(477), Antenna Design and Analysis(225), Bacteriophages and microbial interactions(205), Full-Duplex Wireless Communications(169), Plant Virus Research Studies(149)

Publications637 total

Clinical benefit of adding radiation for immune checkpoint inhibitor-refractory Merkel cell carcinoma: A 27-patient analysis

Journal of Investigative Dermatology·2026

Population differences in Merkel cell carcinoma by virus status and anatomic site: A multi-cohort analysis including institutional, SEER, and NCDB data

Journal of the American Academy of Dermatology·2025Open Access

Programming of Checkpoint Blockade Responsive Stem-like T cells in Chronic Viral Infections and CAR T Cell Immunotherapy of Solid Tumors 4757

The Journal of Immunology·2025Open Access

857 Commandeering T cell fates and adoptive T cell therapeutic outcomes in solid tumors using cytokines and de novo engineered mimetics

Regular and Young Investigator Award Abstracts·2025Open Access

599 The MATRiX trial: a multicenter, randomized, phase II study of ATR inhibition (via tuvusertib) with or without avelumab in patients with advanced anti-PD-(L)1-refractory merkel cell carcinoma

Regular and Young Investigator Award Abstracts·2025Open Access

Circulating Neoantigen- and Viral Oncoprotein–Specific CD8+ T Cells Share a Transcriptional Signature

Cancer Immunology Research·2025

A single dose of neoadjuvant radiation for Merkel cell carcinoma: Complete pathologic response with minimal morbidity in a rapidly growing lesion of the eye

JAAD Case Reports·2025Open Access

Circulating tumor DNA level is associated with time to clinical recurrence in Merkel cell carcinoma: Implications for patient management

Journal of the American Academy of Dermatology·2025

Polyomavirus Antibodies for Merkel Cell Carcinoma Recurrence Detection

1 cited

JAMA Dermatology·2025· 1 citedOpen Access

1669P Prognostic impact of organ-specific metastasis on survival in patients with Merkel cell carcinoma

Annals of Oncology·2025

Real-world outcomes of patients receiving salvage therapies for immune checkpoint inhibitor-resistant Merkel cell carcinoma: a rationale for future clinical trials

2 cited

Journal for ImmunoTherapy of Cancer·2025· 2 citedOpen Access

Risk of disease progression after discontinuing immunotherapy in 105 patients with Merkel cell carcinoma who responded to PD-1 pathway blockade

2 cited

Journal for ImmunoTherapy of Cancer·2025· 2 citedOpen Access

Merkel cell carcinoma in solid organ transplant recipients: prognosis and response to immunotherapy

1 cited

British Journal of Dermatology·2025· 1 cited

B cell responses specific for polyomavirus-derived oncoprotein are predictive of Merkel cell carcinoma tumor control

2025Open Access

0233 Intralesional talimogene laherparepvec for treatment of advanced merkel cell carcinoma

Journal of Investigative Dermatology·2025

LB1080 Pathologic margin negativity is not a guarantee: The risk of merkel cell carcinoma recurrence can be reduced with a single dose of radiation

Journal of Investigative Dermatology·2025

LB1249 Differential expression of splice variants between responders and non-responders to immunotherapy in merkel cell carcinoma

Journal of Investigative Dermatology·2025

Dual Checkpoint Blockade in Merkel Cell Carcinoma: Lessons from CheckMate 358 and the Questions That Remain

1 cited

Journal of Cutaneous Oncology·2025· 1 citedOpen Access

Treatment and disease-specific survival differences among veterans with Merkel cell carcinoma

Journal of the American Academy of Dermatology·2025

The MATRiX trial: A multicenter, randomized, phase II study of ATR inhibition (via tuvusertib) with or without avelumab in patients with advanced anti-PD-(L)1–refractory Merkel cell carcinoma.

2 cited

Journal of Clinical Oncology·2025· 2 cited

page 1 of 32Next →

Frequent Co-authors

Shailender Bhatia(14), Jayasri G. Iyer(12), Kelly G. Paulson(12), Bianca D. Lemos(7), Ragini R. Kudchadkar(6), Thomas Olencki(6), William H. Sharfman(6), Suzanne L. Topalian(6), Célèste Lebbé(6), Michi M. Shinohara(5), Janis M. Taube(5), Karl D. Lewis(5), Christopher K. Bichakjian(5), David R. Byrd(5), Astrid Blom(5), Kishwer S. Nehal(5), Denise A. Galloway(5), Evan J. Lipson(4), Steven P. Fling(4), Lisa Lundgren(4)